Literature DB >> 25611114

Why does rate of bone density loss not predict fracture risk?

William D Leslie1, Sumit R Majumdar, Suzanne N Morin, Lisa M Lix.   

Abstract

CONTEXT: Intuitively, rapid bone mineral density (BMD) loss should predict fracture risk independently of current BMD, but studies have not confirmed this. We hypothesized that measurement error when characterizing rates of BMD loss might explain this paradox.
OBJECTIVE: To examine the importance of measurement error in predicting BMD loss. DESIGN AND
SETTING: Retrospective registry study using BMD results for Manitoba, Canada. PATIENTS: Untreated women age 50 years and older with three femoral neck BMD tests. MAIN OUTCOME MEASURES: Correlation in annualized rates of BMD change for interval 1 (first to second scan) versus interval 2 (second to third scan) with confirmatory model-based simulations that varied measurement error and testing intervals.
RESULTS: Five hundred forty two women with a mean age of 62 years had BMD measurements separated by a mean of 3.5 years for interval 1 and 3.4 years for interval 2. Mean femoral neck BMD loss was stable (-0.5% per year for interval 1, -0.6% per year for interval 2) with a weak negative correlation between intervals (r = -0.11, P = .01). There were no significant correlations for BMD change at the total hip (r = 0.01, P = .74) or total spine (r = -0.01, P = .77). Simulations showed low explained variation for BMD change between intervals 1 and 2 (<20%). To explain 50% of the variation of BMD change between intervals 1 and 2 required a BMD measurement error ≤ 0.008 g/cm(2) or a BMD testing interval ≥ 5 years.
CONCLUSIONS: The low correlation between past and future BMD loss helps explain why the rate of BMD loss is unlikely to be helpful for refining fracture risk.

Entities:  

Mesh:

Year:  2015        PMID: 25611114     DOI: 10.1210/jc.2014-3777

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Urinary N-Telopeptide as Predictor of Onset of Menopause-Related Bone Loss in Pre- and Perimenopausal Women.

Authors:  Albert Shieh; Gail A Greendale; Jane A Cauley; Carrie Karvonen-Gutierrez; Joan Lo; Arun S Karlamangla
Journal:  JBMR Plus       Date:  2018-12-30

2.  Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Authors:  Nasser Al-Daghri; Jaime C Branco; Olivier Bruyère; Loredana Cavalli; Cyrus Cooper; Bernard Cortet; Bess Dawson-Hughes; Hans Peter Dimai; Stefano Gonnelli; Peyman Hadji; Philippe Halbout; Jean-Marc Kaufman; Andreas Kurth; Medea Locquet; Stefania Maggi; Radmila Matijevic; Jean-Yves Reginster; René Rizzoli; Thomas Thierry; Adolfo Diez-Perez; Maria Luisa Brandi
Journal:  Aging Clin Exp Res       Date:  2019-08-17       Impact factor: 3.636

3.  A retrospective review of the community medicine needs from osteoporosis services in Canada.

Authors:  Gregory A Kline; Christopher J Symonds; Emma O Billington
Journal:  BMC Endocr Disord       Date:  2022-03-26       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.